2025
The implementation of artificial intelligence in serial monitoring of post gamma knife vestibular schwannomas: A pilot study
Singh M, Jester N, Lorr S, Briano A, Schwartz N, Mahajan A, Chiang V, Tommasini S, Wiznia D, Buono F. The implementation of artificial intelligence in serial monitoring of post gamma knife vestibular schwannomas: A pilot study. Clinical Imaging 2025, 123: 110495. PMID: 40388858, DOI: 10.1016/j.clinimag.2025.110495.Peer-Reviewed Original ResearchConceptsGamma knife radiosurgeryVestibular schwannomaPost-GKSTumor growthVS volumeHalting tumor growthRetrospective cohort studyAssess treatment efficacyManual segmentationHearing lossBenign tumorsPaired t-testT1-weighted MRI scansAssess statistical significanceCohort studyDice similarity coefficientNeurological functionTreatment efficacyClinical monitoringMRI scansStatistical significancePercentage changeSchwannomaSpatial overlapTumorPrevalence and risk factors for underlying vestibular weakness in cochlear implant candidates
Reeder A, Shah R, Canner J, Schneider E, Vining E, Kveton J, Schwartz N. Prevalence and risk factors for underlying vestibular weakness in cochlear implant candidates. European Archives Of Oto-Rhino-Laryngology 2025, 1-8. PMID: 40195189, DOI: 10.1007/s00405-025-09361-5.Peer-Reviewed Original ResearchCochlear implant candidatesVestibular weaknessImplant candidatesSeverity of hearing lossAudiological risk factorsRisk factorsDesignRetrospective cohort studyHigh riskCI candidatesHearing earIndicator of high riskAudiological dataHearing lossVestibular evaluationVNG testCaloric testUnilateral weaknessVestibular functionVestibular dysfunctionStudy designRetrospective cohort studyBilateral weaknessCohort studyAcademic hospitalDemographic variablesMedical comorbidities
2024
Over‐The‐Counter Hearing Aids: Are They Safe and Effective?
Shah R, Wilkins S, Panth N, Tyagi S, Dunn H, Bell M, Norgaard S, Guyer E, Schwartz N. Over‐The‐Counter Hearing Aids: Are They Safe and Effective? Otolaryngology 2024, 171: 1017-1026. PMID: 38769863, DOI: 10.1002/ohn.817.Peer-Reviewed Original ResearchOver-the-counter hearing aidsHearing aidsHearing lossOver-the-counterMild-to-moderate hearing lossModerate hearing lossOver-the-counter devicesEfficacy of prescriptionHearing levelPrescriptionFood and Drug AdministrationHearingStatistically significant advantageAverage differenceSafety profileAIDSDrug AdministrationAudioscanEfficacySafetyLoss patternsDifferencesTestStatisticallySignificant advantageThe Safety and Efficacy of Hydroxyapatite Repair of Cholesteatoma Skull Base Defects
Shah R, Reeder A, Wilkins S, Kveton J, Schwartz N. The Safety and Efficacy of Hydroxyapatite Repair of Cholesteatoma Skull Base Defects. OTO Open 2024, 8: e151. PMID: 38863486, PMCID: PMC11165677, DOI: 10.1002/oto2.151.Peer-Reviewed Original ResearchSkull base defectsLabyrinthine fistulaTegmen defectsCanal wallBase defectsRate of postoperative infectionMedical records of patientsRate of cholesteatoma recurrenceCholesteatoma recidivism ratesSemicircular canal fistulaSensorineural hearing lossElectronic medical records of patientsRate of recurrenceRecords of patientsRepair skull base defectsInner ear fistulaNonstatistically significant differenceHydroxyapatite groupCWD surgeryCWU surgeryPostoperative audiogramsCholesteatoma recurrenceMastoid infectionHearing lossPostoperative infection
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply